Research-use-only context. This article compares peptide delivery routes as an analytical, pharmacology-of-formats reference for laboratory research. It provides no administration or usage guidance for any human or animal use. American Peptides research peptides are for in vitro research only; American Peptides Melts™ are dietary supplements (see the label and the disclaimer at the end).
Research peptides are studied across four delivery routes: the parenteral (reconstituted-vial) format, intranasal (nasal spray), oral and sublingual (including dissolving strips), and topical. The routes differ mainly in bioavailability — how much of the intact peptide reaches circulation in pharmacokinetic studies — and in onset, enzymatic stability, and handling. This guide explains those differences and where each needle-free format fits.
For years, the default research format for a peptide was a lyophilized powder in a vial, reconstituted into solution. That parenteral format is still the workhorse of the field. But two needle-free formats have become far more common in the research and wellness catalog — nasal sprays and dissolving strips — and understanding why the delivery route changes the science is the difference between choosing a format on habit versus choosing it on evidence.
The four delivery routes at a glance
Every route is a trade-off between how efficiently the peptide survives to reach circulation and how convenient it is to handle. The comparison below summarizes how each is characterized in the pharmacokinetic literature.
| Route | Format | Relative bioavailability (research characterization) | Onset profile | Key limiting factor |
|---|---|---|---|---|
| Parenteral | Reconstituted solution from a vial | Highest — bypasses the gut entirely | Depends on the solution | Requires reconstitution; needle-based handling |
| Intranasal | Metered nasal spray | Moderate — absorbed across the nasal mucosa | Rapid in research models | Small volume per actuation; mucosal clearance |
| Sublingual / oral-mucosal | Dissolving strip, troche | Variable — can partly bypass first-pass metabolism | Moderate | Contact time and peptide stability in the mouth |
| Oral (swallowed) | Capsule, tablet | Lowest for most peptides — degraded in the gut | Slow | First-pass metabolism and enzymatic breakdown |
The single biggest driver in that table is the gut. Peptides are chains of amino acids, and the digestive tract is engineered to break amino-acid chains apart. Any route that avoids the gut — parenteral, intranasal, and to a partial degree sublingual — preserves more of the intact molecule, which is why those formats dominate peptide research.
The parenteral (reconstituted-vial) format
The traditional research format is a freeze-dried peptide in a vial, redissolved into a working solution. Its appeal is chemical: the parenteral route delivers the reconstituted peptide without passing it through the digestive tract, so bioavailability is characterized as the highest of the four routes. The trade-offs are handling-related — the vial must be reconstituted correctly from a lyophilized powder, stored cold, and handled with needle-based tools. For a lab that already runs this workflow, it remains the reference standard. For everyone else, the friction of reconstitution and needles is exactly what the needle-free formats remove.
Intranasal delivery: the nasal-spray research route
The nasal cavity is lined with a thin, highly vascular epithelium sitting directly beneath the surface. In pharmacokinetic research, that anatomy makes the intranasal route attractive: a metered spray deposits solution onto the mucosa, where a fraction is absorbed rapidly without ever entering the gut. For certain small peptides studied in the neuroscience literature, the nasal route has also been examined for direct nose-to-brain transport pathways, which is why compounds like Selank and Semax are so often studied in nasal-spray form.
American Peptides offers this research format as pre-mixed, ready-to-use sprays — no reconstitution, no needles:
- Selank Nasal Spray — a synthetic heptapeptide studied for GABAergic and anxiolytic-pathway signaling in research models.
- Semax Nasal Spray — an ACTH-fragment-derived peptide studied for BDNF and neurotrophic-pathway interactions.
- Selank + Semax Nasal Spray — a combined-format research spray.
Because the delivered volume per actuation is small, the nasal route is characterized by moderate bioavailability relative to the parenteral format, offset by its speed and its needle-free convenience. Mucosal clearance — the nose's natural tendency to move fluid toward the throat — is the main variable researchers control for.
Oral and sublingual delivery: dissolving strips and the oral-mucosal route
Swallowing a peptide is the least efficient route, because first-pass metabolism in the gut and liver degrades most of the intact molecule before it reaches circulation. The sublingual and oral-mucosal route is a partial workaround: a strip or troche held in the mouth dissolves against the mucous membranes, where a portion of the payload can be absorbed directly into local circulation and partly bypass that first pass. Contact time and the compound's stability in saliva are the limiting factors.
This is the science behind the dissolving-strip format. American Peptides Melts™ use it in a fast-dissolving strip — no pills, no water, no reconstitution:
- Melts™ Brain-Fuel Dissolving Strips — a focus-and-energy dietary supplement (Japanese Mint) balanced with L-Theanine.
- Melts™ NAD+ Dissolving Strips — an NAD+ dietary supplement (Lemon Drop) formulated for cellular-health support.
- Melts Pro™ Selank + Semax Dissolving Strips — a combined dissolving-strip format.
Why the delivery route changes the science
Choosing a format is really choosing a set of pharmacokinetic conditions. Four properties move with the route:
- Bioavailability — the fraction that survives to circulation. Highest parenterally, lowest for swallowed oral, with intranasal and sublingual in between.
- First-pass metabolism — only the swallowed-oral route is fully subject to it; nasal and sublingual routes largely avoid it.
- Onset — the nasal mucosa's rich blood supply makes intranasal onset fast in research models; swallowed oral is slowest.
- Enzymatic stability — every non-parenteral route exposes the peptide to some enzymatic environment (saliva, mucus, gut), so formulation and contact time matter more than they do in a vial.
None of these makes one route universally "better." They make each route appropriate for different questions — which is exactly why a modern peptide catalog carries all of them.
Needle-free peptide formats: what's available now
If the friction of reconstitution and needles is the barrier, the needle-free formats are the answer. The two most established are the ones above: metered nasal sprays for the intranasal route, and dissolving strips for the oral-mucosal route. Both arrive ready to use, ship without a cold-chain reconstitution step, and remove needle-based handling entirely. You can browse the full lineup on the American Peptides catalog, and every research peptide ships with a third-party Certificate of Analysis so purity and identity are verifiable regardless of format.
Frequently Asked Questions
Are there peptides that don't require needles?
Yes. Needle-free peptide formats include metered nasal sprays (the intranasal route) and dissolving strips (the oral-mucosal route). Both arrive pre-mixed and ready to use, with no reconstitution and no needle-based handling, which is why they have become popular alternatives to the traditional reconstituted-vial format.
What is a peptide nasal spray?
A peptide nasal spray is a pre-mixed solution delivered as a metered mist to the nasal mucosa. In pharmacokinetic research the nasal route is studied because the thin, vascular nasal lining can absorb a fraction of the peptide rapidly without passing it through the gut. Selank and Semax are commonly studied in this format.
Do dissolving-strip peptides actually work as a delivery format?
The sublingual and oral-mucosal route lets a portion of the payload absorb across the membranes of the mouth and partly bypass first-pass metabolism. Bioavailability by this route is variable and depends on contact time and the compound's stability in saliva, which is why dissolving strips are formulated specifically for fast oral-mucosal dissolution.
Which delivery method has the highest bioavailability?
The parenteral (reconstituted-vial) route is characterized in the literature as having the highest bioavailability because it bypasses the digestive tract entirely. Intranasal and sublingual routes offer moderate, needle-free bioavailability, while swallowed oral capsules are lowest for most peptides due to gut degradation.
Are needle-free research peptides still research-use only?
Yes. American Peptides research peptides — including the nasal-spray format — are sold strictly for laboratory research use only, regardless of delivery format. The Melts™ dissolving strips are a separate category of dietary supplements. Always check the individual product label and its disclaimer.
To go deeper on the fundamentals, start with What Are Research Peptides?, then review Lyophilized Peptides Explained and the reconstitution chemistry guide. Verify identity and purity for any format on the COA library.
Reviewed by the American Peptides Education Team. Educational content only — not medical advice.
This article is for laboratory research reference only. American Peptides research peptides are sold strictly for in vitro research and are not for human consumption. American Peptides Melts™ are dietary supplements; those statements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
Compliance Notice: American Peptides research peptides are sold strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. Dietary-supplement products are separately labeled as such. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution's safety protocols and applicable laws.
